Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Search. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments, as well as workforce solutions, including MSP, OWS, RPO, IRP, EMR, and consulting services. It serves public and private acute care and non-acute care hospitals, government facilities, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The Search segment offers retained and contingent search services for physicians, healthcare executives, and other healthcare professionals, as well as recruitment process outsourcing. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
IPO Year: 2001
Exchange: NASDAQ
Website: crosscountryhealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/10/2024 | Outperform → Mkt Perform | Barrington Research | |
| 12/6/2023 | Mkt Perform | JMP Securities | |
| 11/3/2023 | $32.00 → $21.00 | Buy → Hold | Jefferies |
| 6/26/2023 | Outperform | William Blair | |
| 3/10/2023 | $30.00 | Buy | Loop Capital |
| 10/5/2022 | $36.00 | Buy → Hold | Truist |
| 2/24/2022 | $33.00 → $42.00 | Buy | Benchmark |
| 1/27/2022 | $18.00 → $27.00 | Hold → Buy | Jefferies |
| 8/16/2021 | $13.50 → $19.00 | Neutral | Credit Suisse |
| 8/5/2021 | $22.00 | Hold → Buy | Benchmark |
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
Cross Country Healthcare, Inc. (the Company) (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408 (23 ) % (5 ) % Gross profit margin* 20.0 % (40 ) bps — bps Net loss attributable to common stockholders $ (490 ) (118 ) % 87 % Diluted EPS $ (0.02 ) $ (0.10 )
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 6, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 6th through November 20th on the Company's website and a replay of the
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 2024 Revenue $ 339,771 (37 ) % (10 ) % Gross profit margin* 20.8 % (200 ) bps 40 bps Net (loss) income attributable to common stockh
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, July 31, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, July 31, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from July 31st through August 14th on the Company's website and a replay of the conferen
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2024 vs Q1 2024 vs Dollars are in thousands, except per share amounts Q1 2024 Q1 2023 Q4 2023 Revenue $ 379,174 (39) % (8) % Gross profit margin* 20.4 % (200) bps (150) bps Net income attributable to common stockholders $ 2,692 (
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its first quarter 2024 financial results on Wednesday, May 1, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, May 1, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from May 1st through May 15th on the Company's website and a replay of the conference call wi
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its fourth quarter and full year 2023 financial results on Wednesday, February 21, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, February 21, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from February 21st through March 6th on the Company's website and
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2023 financial results on Wednesday, November 1, 2023 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 1, 2023. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 1st through November 15th at the Company's website and a replay of th
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its second quarter 2023 financial results on Wednesday, August 2, 2023 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, August 2, 2023. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from August 2nd through August 16th at the Company's website and a replay of the confe
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its first quarter 2023 financial results on Wednesday, May 3, 2023 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, May 3, 2023. This call will be webcast live and can be accessed at the Company's website at ir.crosscountryhealthcare.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from May 3rd through May 17th at the Company's website and a replay of the conferen
Cross Country stockholders to receive $18.61 per share Expands Aya's client service and delivery capabilities with Cross Country's nearly 40-year history of clinical excellence and quality patient care Provides clinicians with greater flexibility and convenience by tapping into the combined pool of nationwide opportunities, with competitive compensation and a world-class experience Creates immediate stockholder value for Cross Country, through a nearly 67 percent premium Aya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at appr
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1. S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda
Cross Country Healthcare, Inc., (NASDAQ:CCRN), a leading provider of advisory and workforce solutions including contingent staffing, permanent placement, and other consultative services for healthcare clients, has appointed Phillip Noe to the role of Chief Information Officer (CIO). Noe replaces Bill Halnon who is retiring, and will report directly to Kevin C. Clark, Co-founder and CEO. He commences May 10, 2021. "Phil's appointment reflects the ongoing evolution of our digital transformation at Cross Country," said Kevin C. Clark, Co-founder and Chief Executive Officer of Cross Country Healthcare. "His extensive experience in information technology spans every aspect of the software engin
Cross Country Healthcare, Inc. (the Company) (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408 (23 ) % (5 ) % Gross profit margin* 20.0 % (40 ) bps — bps Net loss attributable to common stockholders $ (490 ) (118 ) % 87 % Diluted EPS $ (0.02 ) $ (0.10 )
Cross Country Healthcare, Inc. ("Cross Country" or the "Company") (NASDAQ:CCRN) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare. As previously disclosed, Cross Country and Aya Healthcare expect to complete the transaction in the second half of 2025, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Upon completion of the transaction, Cross Country will become a private company and its common stock will no longer trade on the NASDAQ. Cross Country will file the final, certified voting results on a Form 8-K with the U.S. Securities and Exch
Cross Country stockholders to receive $18.61 per share Expands Aya's client service and delivery capabilities with Cross Country's nearly 40-year history of clinical excellence and quality patient care Provides clinicians with greater flexibility and convenience by tapping into the combined pool of nationwide opportunities, with competitive compensation and a world-class experience Creates immediate stockholder value for Cross Country, through a nearly 67 percent premium Aya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at appr
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in the UBS Global Healthcare Conference taking place November 11-14, 2024 at the Terranea Resort Hotel in Rancho Palos Verdes, CA. John Martins, President & Chief Executive Officer and Josh Vogel, Vice President, Investor Relations will participate in one-on-one investor meetings on Wednesday, November 13. No formal presentation will be made. About Cross Country Healthcare Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with 38 years of industry experience and insight. We help clients tackle complex labor-related challenges
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 6, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 6th through November 20th on the Company's website and a replay of the
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1. S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Morgan Stanley 22nd Annual Global Healthcare Conference taking place September 4-6, 2024 at the Marriott Marquis in New York City. John Martins, President & Chief Executive Officer and Josh Vogel, Vice President, Investor Relations, will participate in one-on-one investor meetings on Thursday, September 5. No formal presentation will be made. The 17th Annual Barrington Research Virtual Fall Investment Conference taking place September 12, 2024. William J. Burns, Executive Vice President & Chief Financial Officer and Josh Vogel, Vice Presiden
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 2024 Revenue $ 339,771 (37 ) % (10 ) % Gross profit margin* 20.8 % (200 ) bps 40 bps Net (loss) income attributable to common stockh
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, July 31, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, July 31, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from July 31st through August 14th on the Company's website and a replay of the conferen
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in the Citizens JMP Medical Devices and Healthcare Services Forum taking place June 20, 2024 at the Boston Harbor Hotel. John Martins, President & Chief Executive Officer and Josh Vogel, Vice President, Investor Relations, will participate in one-on-one investor meetings. No formal presentation will be made. About Cross Country Healthcare Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with 38 years of industry experience and insight. We help clients tackle complex labor-related challenges and achieve high-quality outcome
SCHEDULE 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
10-Q - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
10-K/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
10-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
DEFA14A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
SCHEDULE 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
Barrington Research downgraded Cross Country from Outperform to Mkt Perform
JMP Securities initiated coverage of Cross Country with a rating of Mkt Perform
Jefferies downgraded Cross Country from Buy to Hold and set a new price target of $21.00 from $32.00 previously
William Blair initiated coverage of Cross Country with a rating of Outperform
Loop Capital initiated coverage of Cross Country with a rating of Buy and set a new price target of $30.00
Truist downgraded Cross Country from Buy to Hold and set a new price target of $36.00
Benchmark reiterated coverage of Cross Country Healthcare with a rating of Buy and set a new price target of $42.00 from $33.00 previously
Jefferies upgraded Cross Country Healthcare from Hold to Buy and set a new price target of $27.00 from $18.00 previously
Credit Suisse reiterated coverage of Cross Country Healthcare with a rating of Neutral and set a new price target of $19.00 from $13.50 previously
Benchmark upgraded Cross Country Healthcare from Hold to Buy and set a new price target of $22.00
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13D/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)